Showing 20 articles starting at article 1
Published Wearable monitor detects stress hormone levels across a full 24-hour day (via sciencedaily.com) Original source
Early warning signs of diseases caused by dysfunctional levels of stress hormones could be spotted more easily thanks to a new wearable device developed by researchers.
Published Helping 'good' gut bacteria and clearing out the 'bad' -- all in one treatment (via sciencedaily.com) Original source
Probiotics can help maintain a healthy gut microbiome or restore populations of 'good bacteria' after a heavy course of antibiotics. But now, they could also be used as an effective treatment strategy for certain intestinal diseases, such as Crohn's disease. Researchers have developed a microgel delivery system for probiotics that keeps 'good' bacteria safe while actively clearing out 'bad' ones. In mice, the system treated intestinal inflammation without side effects.
Published Exposure to dioxins can worsen thyroid function (via sciencedaily.com) Original source
Exposure to dioxins can negatively impact thyroid function, according to a study presented Thursday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.
Published New research identifies cells linking chronic psychological stress to inflammatory bowel disease (via sciencedaily.com) Original source
For the first time, cells involved with the communication between stress responses in the brain and inflammation in the gastrointestinal (GI) tract have been identified in animal models. Glial cells, which support neurons, communicate stress signals from the central nervous system (CNS) to the semi-autonomous nervous system within the gastrointestinal (GI) tract, called the enteric nervous system (ENS). These psychological stress signals can cause inflammation and exacerbate symptoms of inflammatory bowel disease (IBD).
Published Study gives insight into cause of severe inflammatory bowel disease (via sciencedaily.com) Original source
Investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. The variant generates changes to DNA that lead to a loss of protein function, which in turn, alters how the body recognizes and handles bacteria, making it less effective at fighting infections.
Published Study sheds light on how IBD can develop (via sciencedaily.com) Original source
A new study could help improve personalized medicine approaches in inflammatory bowel disease by understanding how patients with variants in the PTPN2 gene develop IBD.
Published Study to decode microbe-gut signaling suggests potential new treatment for IBD (via sciencedaily.com) Original source
Fresh insights into how our bodies interact with the microbes living in our guts suggest that a two-drug combination may offer a new way to treat inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
Published Engineered E. coli delivers therapeutic nanobodies to the gut (via sciencedaily.com) Original source
Researchers have succeeded in developing an E. coli-based 'smart microbe' that secretes therapeutic payloads, including antibodies, into the gut. The genetically modified beneficial strain of bacteria blocks intestinal inflammation in a preclinical model of inflammatory bowel disease and has the potential to treat intestinal-based diseases.
Published Researchers create artificial enzyme for fast detection of disease-related hormone in sweat (via sciencedaily.com) Original source
Researchers have developed a handheld sensor that tests perspiration for cortisol and provides results in eight minutes, a key advance in monitoring a hormone whose levels are a marker for many illnesses including various cancers.
Published Digital twin opens way to effective treatment of inflammatory diseases (via sciencedaily.com) Original source
Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently available drugs have little effect on many patients. Using so-called digital twins, researchers have now obtained a deeper understanding of the 'off and on' proteins that control these diseases.
Published Psyllium fiber protects against colitis by activating bile acid sensor, biomedical sciences researchers find (via sciencedaily.com) Original source
Psyllium fiber protects against ulcerative colitis and suppresses inflammation by activating the bile acid nuclear receptor, a mechanism that was previously unrecognized, according to a new study.
Published Ten-minute scan enables detection and cure of the commonest cause of high blood pressure (via sciencedaily.com) Original source
Doctors have used a new type of CT scan to light up tiny nodules in a hormone gland and cure high blood pressure by their removal. The nodules are discovered in one-in-twenty people with high blood pressure.
Published Compound reverses gut inflammation in mice (via sciencedaily.com) Original source
A new drug acts like a master reset switch in the intestines. The compound, called FexD, has previously been found to lower cholesterol, burn fat, and ward off colorectal cancer in mice. Now, the team reports that FexD can also prevent and reverse intestinal inflammation in mouse models of inflammatory bowel disease.
Published Rheumatoid arthritis drugs lower risk of heart disease, study shows (via sciencedaily.com) Original source
Commonly used drugs that reduce joint inflammation in patients with rheumatoid arthritis also reduce vascular inflammation and cardiovascular risk, finds a new study.
Published New oral compound may help prevent and treat osteoporosis, researchers find (via sciencedaily.com)
Researchers identified an oral compound that influences components of the parathyroid hormone signaling pathway to increase bone formation and bone mass in mice.
Published Common immune cells can prevent intestinal healing (via sciencedaily.com)
B cells are critical to the proper functioning of the immune system. However, researchers have shown that they can sometimes do more harm than good, as their numbers greatly increase after bowel damage, preventing the tissue from healing. The results can be of significance to the treatment of inflammatory bowel disease.
Published To trigger Crohn's disease, pathogenic bacteria co-opt a genetic susceptibility (via sciencedaily.com)
Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn's disease, according to a new study. These findings could one day help doctors better select targeted treatments for patients with this immune disorder. This particular host gene, called AGR2, encodes part of the cell's machinery that helps prepare new proteins properly so that they can help repel 'bad' bacteria. When anything from microbes to inflammatory conditions disrupts this process, protein production gets backed up, stressing the cell. Extremes in the expression of AGR2 -- when it becomes too active or just silent -- are associated with such stress and the cell's response to it, and formed the basis of the study described Nov. 15 in Cell Reports.
Published Recreating the adrenal gland in a petri dish (via sciencedaily.com) Original source
A team coaxed stem cells to take on the characteristics and functions of a human adrenal gland, progress that could lead to new therapies for adrenal insufficiencies and a deeper understanding of the genetics of such disorders.
Published Hormone discovery could predict long term health of men (via sciencedaily.com) Original source
Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.
Published New drug can successfully treat patients typically resistant to high blood pressure treatment (via sciencedaily.com) Original source
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial.